Postdoctoral Research, Washington University in St Louis, Organic/Polymer Chemistry, March 2002- February 2005 (with Professor Karen L. Wooley)
Ph.D., Indian Institute of Technology (IIT), KGP, India, Synthetic Organic Chemistry, March 2002; Advisor: Professor J. K. Ray, Dissertation Title: “Design, Synthesis, Bioactivity, and Molecular Association of Polycyclic Aza and Thiaarenes”
July’10 – July ’13
Assistant Professor in Medicine, Research
Cardiovascular division, Washington University School of Medicine, Saint Louis, MO
Aug ’07 – June’10:
Instructor in Medicine, Research
Cardiovascular division, Washington University School of Medicine, Saint Louis, MO
Feb ’05 – Nov ‘06:
Intellectual Property Analyst; Chemistry and biosciences
General Electric (GE) Global Research, John F. Welch Technology Centre (JFWTC), Bangalore
Prof. Dipanjan Pan, MS, PhD, is an expert in nanomedicine, molecular imaging and drug delivery. He is presently a tenured Associate Professor in Bioengineering and Materials Science and Engineering and Institute of Sustainability in Energy and Environment in University of Illinois, Urbana-Champaign. He also holds a full faculty position with Beckman Institute for Advanced Science and Technology, University of Illinois Cancer Center and recently joined newly started Carle-Illinois College of Medicine. He Administratively directs the Professional Masters in Engineering Program in Bioengineering within the College of Engineering. He is also an Associate course director for the newly founded engineering inspired Carle-Illinois school of medicine. Prior to coming to Illinois, he was a faculty in Washington University School of Medicine, St Louis. Prof Pan’s lab uniquely merges fundamental chemistry, biology and engineering to bring solution to today’s healthcare problems. His research is highly collaborative and interdisciplinary centering on the development of novel materials for biomedical applications, immune-nanomedicine and targeted therapies for stem-like cancer cell with phenotypically screened nanomedicine platforms. Over the years, this research has resulted in more than 100 high impact peer reviewed publications in scientific journals, numerous conference abstracts and has been supported by external funding from NIH, NSF, DoD, American Heart Association and other private/foundational funding sources. Prof. Pan edited and co-written two books published from Taylor and Francois (Nanomedicine: A Soft Matter Perspective, ISBN-13: 978-1466572829) and Springer (Personalized Medicine with a Nanochemistry Twist: Nanomedicine (Topics in Medicinal Chemistry, ISBN-13: 978-3319335445). He holds multiple patents (8 granted US patents), several ongoing clinical trials and is the founder of three University based early start-ups. He is the CEO/President for a biotechnology start-up Vitruvian Biotech dedicated to develop novel image guided therapies. He also co-founded InnSight Technologies dedicated to nanotechnology based application for ocular diseases. His other company Kalocyte, which he cofounded with his clinical collaborators, develops artificial oxygen career. His technology has been licensed for commercial development multiple times. He serves as study section review board member for NIH, CDMRP (DoD), NSF and multiple review committee member for American Heart Association. In 2016 he received Nanomaterials Letter (NML) Researcher award, in 2017 an Young Innovator Award from Biomedical Engineering Society (BMES) and most recently Dean’s Award for Research Excellence in 2018. He is an elected fellow of Royal Society of Chemistry, a Fellow of American Heart Association and an elected fellow of American College of Cardiology. Professor Pan is an editorial board member of Scientific Reports (Nature Publishing) and an editorial advisory board member of Molecular Pharmaceutics (ACS).